It emerged on Wednesday that Moderna Inc (MRNA.O) could confront a patent violation lawsuit over its COVID-19 vaccine. The speculations arose after a federal appeals court on Wednesday dismissed its challenge to patents being owned by the Arbutus Biopharma Corp (ABUS.O). According to the administrative panel’s findings, Arbutus’ patents, which may cover technology used in the vaccines, were not apparent in light of previously known science and so were found valid.
